Kyle A. Emmitte

City:

Aledo, Texas

Country:

United States

Published Applications:

Last publication date:

2024-01-18

Top Assignees for applications by Kyle A. Emmitte

The entities that hold a legal rights for patent applications filed by inventor Emmitte Kyle A.:

VANDERBILT UNIVERSITY 4 Nashville, TN United States
University of North Texas Health Science Center 2 Fort Worth, TX United States

Recent patent applications by Emmitte Kyle A.

Kyle A. Emmitte from Aledo, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-01-18

US20240016828A1

Human necessities

INHIBITION OF NGLY1 FOR THE TREATMENT OF CANCER

#2 | 2021-07-08

US20210205349A1

Human necessities

Inhibition of NGLY1 for the treatment of cancer

#3 | 2018-05-03

US20180118746A1

Chemistry; metallurgy

Substituted pyrrolo[3,4-e]indolizines, imidazo[1,2-a]pyrrolo[3,4-e]pyridines, pyrrolo[3,4-e][1,2,4]triazolo[1,5-a]pyridines and pyrrolo[3,4-e][1,2,4]triazolo[4,3-a]pyridines as positive allosteric modulators of muscarinic acetylcholine receptor M1

#4 | 2018-03-15

US20180072674A1

Chemistry; metallurgy

4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators

#5 | 2018-01-25

US20180022712A1

Chemistry; metallurgy

Negative allosteric modulators of metabotropic glutamate receptor 3

#6 | 2016-04-07

US20160096833A1

Chemistry; metallurgy

Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5

InventorID:

1493779 ⎘